Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease

NCT02503501 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

49

Enrollment

OTHER

Sponsor class

Stopped Study will not have power to show a difference between groups.

Conditions

Mild Cognitive Impairment
Alzheimer's Disease (AD)

Interventions

DRUG: Insulin glulisine
DRUG: Placebo

Sponsor

HealthPartners Institute